Immunic, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Immunic, Inc. (IMUX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $281.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-11
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $281.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $88.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $428.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $449.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $281.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $88.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $428.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $449.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $444.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $281.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $740.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $433.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $433.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $433.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $758.00K 10-K · filed 2024-02-22 |
| 2023-09-30 | $758.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $820.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $820.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $647.00K 10-K · filed 2023-02-23 |
| 2022-09-30 | $528.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $289.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $303.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $457.00K 10-K · filed 2022-02-24 |
| 2021-09-30 | $461.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $459.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $467.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $348.00K 10-K · filed 2021-02-26 |
| 2020-09-30 | $337.00K 10-Q · filed 2020-11-06 |
| 2019-12-31 | $193.00K 10-K · filed 2020-03-16 |
| 2018-12-31 | $469.00K 10-K · filed 2019-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |